Literature DB >> 16170360

Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.

M R Bhonde1, M-L Hanski, M Notter, B F Gillissen, P T Daniel, M Zeitz, C Hanski.   

Abstract

Knowledge of the type of biological reaction to chemotherapy is a prerequisite for its rational enhancement. We previously showed that irinotecan-induced DNA damage triggers in the HCT116p53(wt) colon carcinoma cell line a long-term cell cycle arrest and in HCT116p53(-/-) cells apoptosis (Magrini et al., 2002). To compare the contribution of long-term cell cycle arrest and that of apoptosis to inhibition of cell proliferation after irinotecan-induced DNA damage, we used this isogenic system as well as the cell lines LS174T (p53(wt)) and HT-29 (p53(mut)). Both p53(wt) cell lines responded to damage by undergoing a long-term tetraploid G1 arrest, whereas the p53(mut) cell lines underwent apoptosis. Cell cycle arrest as well as apoptosis caused a similar delay in cell proliferation. Irinotecan treatment also induced in mouse tumours derived from the p53(wt) cell lines a tetraploid G1 arrest and in those derived from the p53-deficient cell lines a transient G2/M arrest and apoptosis. The delay of tumour growth was in the same range in both groups, that is, arrest- and apoptosis-mediated tumour growth inhibition was comparable. In conclusion, cell cycle arrest as well as apoptosis may be equipotent mechanisms mediating the chemotherapeutic effects of irinotecan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16170360     DOI: 10.1038/sj.onc.1209017

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Phytochemical induction of cell cycle arrest by glutathione oxidation and reversal by N-acetylcysteine in human colon carcinoma cells.

Authors:  R Y Odom; M Y Dansby; A M Rollins-Hairston; K M Jackson; W G Kirlin
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

2.  Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cells.

Authors:  Hong Zhu; Ze-Hong Miao; Min Huang; Jian-Ming Feng; Zhi-Xiang Zhang; Jin-Jian Lu; Yu-Jun Cai; Lin-Jiang Tong; Yu-Fang Xu; Xu-Hong Qian; Jian Ding
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

3.  In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis.

Authors:  Eric Guérin; Wolfgang Raffelsberger; Erwan Pencreach; Armin Maier; Agnès Neuville; Anne Schneider; Philippe Bachellier; Serge Rohr; Amélie Petitprez; Olivier Poch; Dino Moras; Pierre Oudet; Annette K Larsen; Marie-Pierre Gaub; Dominique Guenot
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 4.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.

Authors:  Cindrilla Chumduri; Bernhard Gillissen; Anja Richter; Antje Richter; Ana Milojkovic; Tim Overkamp; Anja Müller; Christiane Pott; Peter T Daniel
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

6.  Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.

Authors:  Mandar Ramesh Bhonde; Marie-Luise Hanski; Jenny Stehr; Britta Jebautzke; Roser Peiró-Jordán; Henry Fechner; Kazunari Kazushige Yokoyama; Weei-Chin Lin; Martin Zeitz; Christoph Hanski
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

7.  A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.

Authors:  Anna V Gaponova; Anna S Nikonova; Alexander Deneka; Meghan C Kopp; Alexander E Kudinov; Natalia Skobeleva; Vladimir Khazak; Luisa S Ogawa; Kathy Q Cai; Kelly E Duncan; James S Duncan; Brian L Egleston; David A Proia; Yanis Boumber; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2016-06-07       Impact factor: 12.531

8.  P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.

Authors:  Chong Zhang; Hong Zhu; Xiaochun Yang; Jianshu Lou; Difeng Zhu; Wei Lu; Qiaojun He; Bo Yang
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-02       Impact factor: 4.553

Review 9.  Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.

Authors:  Marco H Hofmann; Daniel Gerlach; Sandra Misale; Mark Petronczki; Norbert Kraut
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

10.  Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G₂ checkpoint arrest.

Authors:  Angela Poehlmann; Caroline Habold; Diana Walluscheck; Kathrin Reissig; Khuloud Bajbouj; Oliver Ullrich; Roland Hartig; Hala Gali-Muhtasib; Antje Diestel; Albert Roessner; Regine Schneider-Stock
Journal:  J Cell Mol Med       Date:  2011-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.